Zum Inhalt springen
OffenFörderungMedical equipment and pharma

Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases[E8]

UnknownEuropean Commission[E1]

In einfachen Worten

Was gefördert wird
Call: Cluster 1 - Health (Two stage - 2027). Type of action: HORIZON Research and Innovation Actions. Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Developing and using new tools, technologies and digital solutions for a healthy society”.
Wer kann sich bewerben
  • EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.
  • Offen für: Universities and research
  • Phase: Prototype and MVP
Termine
Öffnet am 29. Okt. 2026.Schließt:
Frist des Fördergebers: 17. Feb. 2027, 01:00 Mitteleuropäische Zeit (UTC+1). UTC: 17. Feb. 2027, 00:00 UTC.
Fördermittel
EUR 10.000.000 insgesamtArt der Förderung: Grant.
Fördergeber
European CommissionWeitere Förderungen dieses Fördergebers ansehen.
Leitfaden und Antrag

Leitfaden, Regeln und Antragsformular stehen auf der Seite des Fördergebers. Lesen Sie sie vor dem Antrag.

Öffnet[E6]
29. Okt. 2026
Schließt[E2]
17. Feb. 2027, 01:00 Mitteleuropäische Zeit (UTC+1)
Fördersumme gesamt[E9]
EUR 10.000.000
Pro Antragsteller
Nicht angegeben
Zuletzt geprüft
vor 6 Stunden

Zur Förderung

Aus der Bekanntmachung

Call: Cluster 1 - Health (Two stage - 2027). Type of action: HORIZON Research and Innovation Actions. Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Developing and using new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes: Clinical researchers and developers have access to novel predictive biomarkers to guide a more accurate assessment of disease progression and treatment response and tackle the unmet clinical needs of non-communicable chronic diseases. Clinicians and healthcare professionals use clinically validated predictive biomarkers for implementing more effective clinical research and personalised medicine with better health outcomes in chronic non-communicable diseases. Key stakeholders have access to trustworthy Artificial Intelligence (AI) tools to guide the development of multimodal predictive biomarkers of higher accuracy and clinical value when compared to the established practice. The citizens benefit of better health outcomes thanks to improved clinical guidelines and the implementation of effective biomarker-guided clinical research and personalised healthcare. Scope: Biomarkers [1] are invaluable tools for improving patient outcomes, guiding treatment decisions, accelerating personalised medicine, more effective clinical research and the development of better medicines. However, des…[E3]

Wer kann sich bewerben

Die Angaben der Bekanntmachung werden so gezeigt, wie die Quelle sie veröffentlicht hat. Die Fakten und Anforderungen, die wir herausziehen, sind auf Englisch.

  • Offen fürUniversities and research. Von SLETOR anhand der Wörter der Ausschreibung zugeordnet.
  • BedingungEU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.[E4]

Risiken und Unbekanntes

  • RisikoThis is a grant, not a contract. Grants usually need a proposal against the funder's criteria, may need partners and often need co-funding.[E5]
  • UnbekanntWe read the funder's listing, not the full guidance or application forms.

Aktualisierungen

  1. Für Angebote geöffnet · 29. Okt. 2026, 07:41 UTC

    The funder published the call with a future closing date.

    Geändert: status, notice type, published at (Quelldatensatz Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage))

  2. Erstmals gesehen · 28. Okt. 2026, 21:22 UTC

    The funder announced the call. Applications have not opened yet.

    Quelldatensatz: Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage)

Belege

9 Angaben

Jede Angabe auf dieser Seite stammt aus der Ausschreibung des Fördergebers. Jeder Eintrag zeigt den Datensatz und das Feld, aus dem er gelesen wurde.

  1. E1

    The funder is European Commission.

    Aus Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage), Feld /metadata/type/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle (öffnet in neuem Tab)

  2. E2

    Proposals must be submitted by 17 Feb 2027, 01:00 Central European time (UTC+1).

    “2027-02-17T00:00:00.000+0000”

    Aus Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage), Feld /metadata/deadlineDate/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle (öffnet in neuem Tab)

  3. E3

    The buyer describes the requirement in the notice.

    “Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Developing and using new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic shou…”

    Aus Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage), Feld /metadata/descriptionByte/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle (öffnet in neuem Tab)

  4. E4

    EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.

    “EU call topic”

    Aus Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage), Feld /metadata/type/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle (öffnet in neuem Tab)

  5. E5

    This is an EU call for proposals.

    “31094502”

    Aus Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage), Feld /metadata/status/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle (öffnet in neuem Tab)

  6. E6

    Applications open on 29 Oct 2026.

    “2026-10-29T00:00:00.000+0000”

    Aus Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage), Feld /metadata/startDate/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle (öffnet in neuem Tab)

  7. E7

    The Funding & Tenders Portal gives the status as open for submission.

    Aus Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage), Feld /metadata/status/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle (öffnet in neuem Tab)

  8. E8

    The notice is titled "Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases".

    Aus Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage), Feld /metadata/title/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle (öffnet in neuem Tab)

  9. E9

    The EU contribution per grant is up to EUR 10,000,000 (from EUR 5,000,000).

    Aus Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage), Feld /metadata/budgetOverview/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle (öffnet in neuem Tab)

Source: EU Funding & Tenders Portal, © European Union, CC BY 4.0. SLETOR shortened and reformatted the text. Datenlizenz: Creative Commons Attribution 4.0 (European Commission) (öffnet in neuem Tab). Persönliche Kontaktdaten aus Bekanntmachungen werden weder gespeichert noch angezeigt.